| Ranked [title] Word list | Historiographs | Help Glossary HistCite Guide About |
| Nodes: 6555, Authors: 15733, Journals: 1105, Cited References: 140610, Words: 8620, Tags: 1
Yearly output | Document Type | Language | Institution | Institution with Subdivision | Country |
| View: Overview | Sorted by LCS. |
| # | Word | Pubs | TLCS | TGCS |
|---|---|---|---|---|
| 401 | DAMAGE | 52 | 362 | 1645 |
| 402 | REVIEW | 42 | 361 | 1214 |
| 403 | ARRAYS | 11 | 360 | 562 |
| 404 | EXTENDED | 8 | 360 | 695 |
| 405 | FORMED | 26 | 360 | 864 |
| 406 | ORGANS | 3 | 358 | 503 |
| 407 | VECTORS | 10 | 358 | 1580 |
| 408 | DELETION | 31 | 357 | 854 |
| 409 | SELECTIVE | 23 | 357 | 641 |
| 410 | CANDIDATE | 8 | 352 | 561 |
| 411 | BLADDER | 40 | 350 | 1004 |
| 412 | PROTOCOL | 13 | 350 | 615 |
| 413 | IN-VIVO | 8 | 348 | 732 |
| 414 | MOTIF | 33 | 348 | 945 |
| 415 | PLASMIDS | 38 | 348 | 1424 |
| 416 | HEMATOLOGIC | 5 | 347 | 499 |
| 417 | LINE | 64 | 346 | 822 |
| 418 | PROGRESSIVE | 9 | 345 | 546 |
| 419 | G-STRAND | 8 | 343 | 425 |
| 420 | CLINICAL | 48 | 342 | 783 |
| 421 | CONTAINS | 19 | 342 | 828 |
| 422 | TRYPANOSOMA-BRUCEI | 22 | 342 | 1023 |
| 423 | MAINTAINS | 5 | 341 | 465 |
| 424 | PLANT | 35 | 339 | 713 |
| 425 | DEFICIENCY | 10 | 336 | 554 |
| 426 | HYPOTHESIS | 14 | 336 | 627 |
| 427 | INVOLVEMENT | 21 | 336 | 833 |
| 428 | RELATED | 33 | 336 | 1259 |
| 429 | BENIGN | 28 | 335 | 813 |
| 430 | BIOLOGY | 58 | 334 | 1489 |
| # | Word | Pubs | TLCS | TGCS |
| 431 | SWITCH | 10 | 334 | 729 |
| 432 | TETRADS | 10 | 334 | 770 |
| 433 | ADULT | 20 | 333 | 568 |
| 434 | CHANGES | 47 | 333 | 730 |
| 435 | NOVA | 16 | 333 | 605 |
| 436 | CILIATES | 31 | 332 | 556 |
| 437 | PROSTATE | 36 | 332 | 837 |
| 438 | CORRELATING | 2 | 329 | 500 |
| 439 | MONO-VALENT | 1 | 329 | 604 |
| 440 | OUTCOMES | 1 | 326 | 492 |
| 441 | RAT | 35 | 326 | 706 |
| 442 | VARIATION | 37 | 326 | 1593 |
| 443 | NATURAL | 20 | 325 | 581 |
| 444 | ORIGINS | 15 | 324 | 1175 |
| 445 | SEQUENCE-SPECIFIC | 18 | 324 | 483 |
| 446 | BREAKS | 27 | 323 | 1613 |
| 447 | CONSERVATION | 14 | 322 | 494 |
| 448 | TUMOR-DERIVED | 3 | 321 | 457 |
| 449 | SENSITIVITY | 19 | 320 | 637 |
| 450 | BONE | 32 | 319 | 753 |
| 451 | LIFESPAN | 16 | 319 | 443 |
| 452 | TEL | 15 | 319 | 641 |
| 453 | GENE-SIZED | 3 | 318 | 405 |
| 454 | TRAP | 13 | 317 | 505 |
| 455 | DEFECTIVE | 17 | 316 | 564 |
| 456 | TRYPANOSOMES | 14 | 316 | 1292 |
| 457 | CONTAIN | 9 | 315 | 543 |
| 458 | HYPOTRICHS | 4 | 314 | 423 |
| 459 | END-REPLICATION | 1 | 312 | 410 |
| 460 | SURVIVAL | 24 | 312 | 575 |
| # | Word | Pubs | TLCS | TGCS |
| 461 | LATE | 11 | 311 | 475 |
| 462 | LIMITS | 6 | 308 | 496 |
| 463 | CDC13P | 8 | 307 | 388 |
| 464 | CILIATED | 12 | 307 | 654 |
| 465 | PARAMECIUM | 48 | 304 | 703 |
| 466 | BASAL | 3 | 303 | 438 |
| 467 | EXTENDS | 7 | 303 | 412 |
| 468 | LOOPS | 6 | 303 | 621 |
| 469 | MAMMALS | 9 | 303 | 374 |
| 470 | PROCESSIVITY | 15 | 303 | 328 |
| 471 | STEM-CELLS | 2 | 303 | 600 |
| 472 | RESIDUES | 9 | 302 | 433 |
| 473 | STABILIZATION | 17 | 300 | 592 |
| 474 | FLUORESCENCE | 27 | 298 | 568 |
| 475 | DEGRADATION | 11 | 297 | 476 |
| 476 | POLYMORPHISM | 23 | 297 | 659 |
| 477 | REQUIREMENT | 8 | 297 | 485 |
| 478 | CLEAVAGE | 18 | 296 | 570 |
| 479 | FATES | 2 | 296 | 300 |
| 480 | INTERSTITIAL | 17 | 294 | 703 |
| 481 | POT | 17 | 293 | 402 |
| 482 | TRISOMY | 3 | 293 | 479 |
| 483 | MAINTAINED | 6 | 291 | 317 |
| 484 | G-TETRAPLEX | 6 | 289 | 540 |
| 485 | THERAPY | 41 | 289 | 687 |
| 486 | EVOLUTIONARILY | 10 | 287 | 615 |
| 487 | CRYSTAL | 14 | 285 | 755 |
| 488 | TARGETING | 39 | 285 | 1409 |
| 489 | IN-VITRO | 10 | 284 | 401 |
| 490 | PREVENTS | 8 | 284 | 360 |
| # | Word | Pubs | TLCS | TGCS |
| 491 | PROCESS | 13 | 283 | 505 |
| 492 | RAPID | 37 | 283 | 739 |
| 493 | TREATMENT | 40 | 283 | 615 |
| 494 | NUCLEIC | 25 | 282 | 891 |
| 495 | OCCURS | 14 | 282 | 570 |
| 496 | UPSTREAM | 14 | 282 | 882 |
| 497 | ACCUMULATION | 11 | 280 | 604 |
| 498 | DEATH | 21 | 280 | 971 |
| 499 | FACTORS | 28 | 280 | 1040 |
| 500 | ALPHA | 28 | 279 | 570 |
| 501 | POINT | 10 | 278 | 546 |
| 502 | NUCLEOLAR | 15 | 276 | 601 |
| 503 | DUAL | 8 | 275 | 374 |
| 504 | PAPILLOMAVIRUS | 16 | 275 | 830 |
| 505 | ANTISENSE | 29 | 274 | 578 |
| 506 | HYBRIDIZATION | 50 | 274 | 732 |
| 507 | MALIGNANCY | 12 | 274 | 496 |
| 508 | DIMERIZES | 2 | 273 | 471 |
| 509 | CERVICAL | 22 | 272 | 660 |
| 510 | DESIGN | 14 | 272 | 597 |
| 511 | MARKER | 19 | 272 | 628 |
| 512 | HYPOTRICHOUS | 21 | 270 | 452 |
| 513 | CONTROLLING | 5 | 269 | 526 |
| 514 | MRNA | 48 | 269 | 581 |
| 515 | SEPARATION | 15 | 268 | 483 |
| 516 | AFFECTS | 10 | 267 | 386 |
| 517 | SPECIFICALLY | 14 | 267 | 467 |
| 518 | ELIMINATION | 13 | 266 | 387 |
| 519 | LENGTHS | 24 | 266 | 417 |
| 520 | STABILIZED | 7 | 264 | 542 |
| # | Word | Pubs | TLCS | TGCS |
| 521 | ENDOTHELIAL | 37 | 263 | 650 |
| 522 | REGULATE | 12 | 263 | 414 |
| 523 | G4-DNA | 6 | 261 | 468 |
| 524 | INVERTED | 17 | 261 | 590 |
| 525 | TISSUE-SPECIFIC | 3 | 261 | 385 |
| 526 | GASTRIC-CANCER | 1 | 260 | 395 |
| 527 | GENERATED | 13 | 259 | 504 |
| 528 | BREAK | 22 | 258 | 1276 |
| 529 | DNA-STRUCTURE | 8 | 258 | 733 |
| 530 | QUADRUPLEXES | 26 | 258 | 583 |
| 531 | TURNOVER | 14 | 257 | 615 |
| 532 | SPONTANEOUS | 16 | 256 | 701 |
| 533 | TELOMERASE-NEGATIVE | 15 | 256 | 374 |
| 534 | MICRONUCLEAR | 25 | 255 | 392 |
| 535 | GENERATION | 15 | 254 | 494 |
| 536 | KINASE | 23 | 254 | 560 |
| 537 | ACA | 8 | 253 | 514 |
| 538 | ACCESS | 6 | 253 | 323 |
| 539 | NUMBER | 15 | 253 | 503 |
| 540 | VARIATIONS | 7 | 253 | 507 |
| 541 | MODIFICATIONS | 7 | 252 | 441 |
| 542 | URINE | 18 | 252 | 667 |
| 543 | ARTIFICIAL | 25 | 251 | 2168 |
| 544 | OLIGONUCLEOTIDE | 23 | 251 | 702 |
| 545 | UNIQUE | 14 | 251 | 588 |
| 546 | CHRONIC | 32 | 250 | 591 |
| 547 | REORGANIZATION | 12 | 250 | 525 |
| 548 | GERM | 24 | 249 | 474 |
| 549 | MEMORY | 11 | 249 | 526 |
| 550 | RATE | 11 | 249 | 319 |
| # | Word | Pubs | TLCS | TGCS |
| 551 | TANDEM | 29 | 249 | 940 |
| 552 | VIABILITY | 8 | 249 | 345 |
| 553 | LONGEVITY | 15 | 248 | 573 |
| 554 | CRISIS | 15 | 247 | 464 |
| 555 | EPITHELIAL-CELLS | 4 | 247 | 480 |
| 556 | EPSTEIN-BARR | 8 | 247 | 429 |
| 557 | INVOLVES | 11 | 247 | 382 |
| 558 | EFFICIENT | 15 | 246 | 600 |
| 559 | MARROW | 22 | 246 | 592 |
| 560 | REGULATES | 22 | 246 | 415 |
| 561 | TRUNCATION | 2 | 246 | 316 |
| 562 | REPLICATING | 16 | 245 | 902 |
| 563 | REQUIREMENTS | 16 | 244 | 473 |
| 564 | RUNAWAY | 2 | 244 | 243 |
| 565 | STAGE | 16 | 244 | 582 |
| 566 | DELTA | 5 | 243 | 350 |
| 567 | LIMITING | 9 | 243 | 403 |
| 568 | POSSIBLE | 36 | 243 | 772 |
| 569 | TISSUE | 32 | 243 | 507 |
| 570 | DIAGNOSIS | 27 | 242 | 664 |
| 571 | ENDOMETRIUM | 9 | 242 | 419 |
| 572 | GENE-MUTATIONS | 1 | 242 | 241 |
| 573 | BIND | 14 | 241 | 461 |
| 574 | LINEARITY | 1 | 241 | 379 |
| 575 | RELIABILITY | 2 | 241 | 379 |
| 576 | RESISTANCE | 29 | 241 | 568 |
| 577 | ANAPHASE | 4 | 240 | 281 |
| 578 | MEMBER | 5 | 240 | 370 |
| 579 | NONTELOMERIC | 5 | 240 | 505 |
| 580 | S-PHASE | 6 | 240 | 430 |
| # | Word | Pubs | TLCS | TGCS |
| 581 | ORAL | 34 | 239 | 496 |
| 582 | DROSOPHILA-MELANOGASTER | 13 | 238 | 487 |
| 583 | INVITRO | 22 | 238 | 1340 |
| 584 | DEREGULATION | 6 | 237 | 331 |
| 585 | ACCELERATE | 3 | 236 | 413 |
| 586 | HELICASE | 19 | 236 | 500 |
| 587 | ACCELERATED | 13 | 234 | 433 |
| 588 | DELETIONS | 19 | 234 | 583 |
| 589 | NONPROCESSIVE | 3 | 234 | 251 |
| 590 | ATAXIA-TELANGIECTASIA | 9 | 233 | 521 |
| 591 | SUGGEST | 3 | 233 | 318 |
| 592 | VERTEBRATES | 3 | 233 | 341 |
| 593 | BETA-SUBUNIT | 3 | 232 | 315 |
| 594 | END-JOINING | 5 | 232 | 616 |
| 595 | HIGHER | 14 | 232 | 465 |
| 596 | INTEGRITY | 17 | 232 | 969 |
| 597 | PEPTIDE | 12 | 232 | 513 |
| 598 | CATIONIC | 6 | 231 | 433 |
| 599 | CONDITIONS | 10 | 231 | 425 |
| 600 | SILENCERS | 5 | 230 | 853 |